West Virginia 2026 Regular Session

West Virginia Senate Bill SB1012

Introduced
2/19/26  
Refer
2/19/26  
Engrossed
3/3/26  
Refer
3/5/26  

Caption

Permitting development of juvenile inpatient substance use disorder treatment beds

Impact

The introduction of SB1012 marks a significant step toward ameliorating the existing gaps in care for juveniles facing substance use challenges. By enabling facilities to expand their treatment capacity specifically for this age group, the bill seeks to enhance access to necessary services, which may lead to better health outcomes and reduced recidivism for young individuals. This move is particularly pertinent given the rising trends in substance use among adolescents, which has been fueled by the ongoing opioid crisis and other substance-related issues affecting the region.

Summary

Senate Bill 1012 proposes amendments to the West Virginia Code to facilitate the establishment of juvenile inpatient substance use disorder treatment beds. Specifically, the bill allows the addition of 100 licensed substance abuse treatment beds reserved for individuals aged 17 and younger, in counties that already have an excess of 250 licensed substance abuse treatment beds. This legislation aims to address the increasing need for specialized treatment options for youth struggling with substance use disorders, a demographic that has been notably underserved in current healthcare infrastructures.

Sentiment

General sentiment towards SB1012 appears to be supportive among healthcare advocates and youth services organizations, who view the expanded treatment options as a prudent step in addressing urgent public health needs. Supporters posit that the bill reflects a commitment to prioritizing youth mental health and providing tailored treatment solutions. However, there also exists a cautious perspective concerning the adequacy of resources and infrastructure to support these new treatment beds, with some stakeholders questioning whether the state can successfully implement and maintain such expansions in a sustainable manner.

Contention

Notable points of contention surrounding SB1012 include concerns regarding the capacity of existing healthcare facilities to safely and effectively manage new pediatric treatment beds. Additionally, some community members express apprehension about the allocation of funding and resources, advocating for comprehensive strategies that go beyond merely increasing bed capacity to include prevention and education initiatives. The discussions around the bill underscore a tension between the urgent need for immediate treatment solutions versus the necessity for comprehensive and long-term strategies to tackle substance use among youth.

Companion Bills

No companion bills found.

Previously Filed As

WV SB723

Relating to clinical inpatient medical treatment centers for substance use disorder

WV SB1013

Prohibiting payment to residential substance use disorder treatment facilities in certain circumstances

WV SB867

Prohibiting payment to residential substance use disorder treatment facilities that do not meet certain requirements

WV HB113

Prohibiting payment to residential substance use disorder treatment facilities that do not meet certain requirements

WV HB3306

Involuntary treatment for substance use disorder (Cassie’s Law)

WV HB3246

Prohibiting expanding drug and alcohol treatment facilities and services in certain counties

WV HB2144

Require Substance Use Disorder inpatient providers to offer patients transportation to certain places upon discharge

WV HB2861

Mental Health and Substance Use Disorders Insurance Coverage Protection Act

WV HB3070

Relating to the requirement of insurance coverage for a nonopioid drug for a person diagnosed with a substance use disorder

WV SCR14

Requesting Joint Committee on Government and Finance study substance use disorder in WV

Similar Bills

No similar bills found.